Use access key #2 to skip to page content.
$6.35 -0.14 (-2.16%)
5/16/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

0

Avatar Rediggles (32.25) Submitted: 4/21/08 2:54 PM : Outperform Start Price: $7.77 EXEL Score: -21.27

Biotech with a lot in the pipeline. Demographic trends show that biotechs will be the source of strong growth going forward.

Report this Post Replies: 0 | Reply

Featured Broker Partners